Who owns ENSYSCE BIOSCIENCES ORD?
- Ticker: ENSC
- CUSIP Number: 293602504
Tip: Access positions for across all investors
Analyze quarterly positions in Ensysce Biosciences Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Ensysce Biosciences Ord stock
Who bought or sold ENSYSCE BIOSCIENCES ORD this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Jane Street | 209k | $61k | 1439% | Jun 2026 |
|
| Adage Capital Partners GP | 150k | $43k | 0% | Jun 2026 |
|
| Virtu Financial | 95k | $28k | 617% | Jun 2026 |
|
| Perceptive Advisors | 87k | $25k | 0% | Jun 2026 |
|
| Citadel Advisors | 86k | $25k | 50% | Jun 2026 |
|
| XTX Topco | 77k | $22k | 216% | Jun 2026 |
|
| Geode Capital Management | 62k | $18k | -16% | Jun 2026 |
|
| Hrt Financial | 54k | $15k | 100% | Jun 2026 |
|
| Susquehanna International | 34k | $9.9k | 100% | Jun 2026 |
|
| Tru Independence Asset Management 2 | 13k | $3.8k | 0% | Jun 2026 |
|
| Two Sigma Securities | 13k | $3.8k | 100% | Jun 2026 |
|
| Vanguard Capital Management | 13k | $3.7k | 0% | Jun 2026 |
|
| Tower Research Capital | 6.1k | $1.8k | 0% | Jun 2026 |
|
| FNY Investment Advisers | 3.0k | $0 | 0% | Jun 2026 |
|
| Barclays | 1.4k | $418.032000 | 100% | Jun 2026 |
|
| SBI Securities | 641.00 | $186.018200 | 32% | Jun 2026 |
|
| BlackRock | 65.00 | $18.999500 | 0% | Jun 2026 |
|
| Clear Street Group | 1.00 | $0 | 100% | Jun 2026 |
|
Who sold out of Ensysce Biosciences Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Vanguard Fiduciary Trust | Mar 2026 | 24k | $13k |
| UBS Group | Mar 2026 | 8.8k | $4.7k |